Invesco Ltd. Has $10.02 Million Stake in Option Care Health, Inc. $OPCH

Invesco Ltd. reduced its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 14.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 286,685 shares of the company’s stock after selling 48,381 shares during the period. Invesco Ltd. owned 0.18% of Option Care Health worth $10,020,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in OPCH. Dimensional Fund Advisors LP grew its holdings in shares of Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company’s stock valued at $92,518,000 after acquiring an additional 591,042 shares in the last quarter. Northern Trust Corp boosted its position in Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company’s stock valued at $60,934,000 after purchasing an additional 278,158 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in Option Care Health by 4.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock valued at $91,209,000 after purchasing an additional 99,574 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in Option Care Health by 6,525,926.1% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company’s stock valued at $52,459,000 after purchasing an additional 1,500,963 shares in the last quarter. Finally, Comerica Bank increased its position in shares of Option Care Health by 13.1% during the 4th quarter. Comerica Bank now owns 1,357,628 shares of the company’s stock worth $31,497,000 after purchasing an additional 157,198 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of Option Care Health stock in a transaction dated Wednesday, August 20th. The stock was bought at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the transaction, the director owned 375,390 shares in the company, valued at $10,191,838.50. The trade was a 10.61% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Timothy P. Sullivan purchased 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The stock was acquired at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the purchase, the director directly owned 49,229 shares of the company’s stock, valued at $1,354,289.79. This represents a 68.43% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Stock Up 3.2%

Option Care Health stock opened at $28.74 on Monday. The company’s 50-day moving average price is $29.92 and its two-hundred day moving average price is $31.76. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The stock has a market cap of $4.66 billion, a P/E ratio of 22.99, a P/E/G ratio of 1.75 and a beta of 0.79. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business’s revenue was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on OPCH shares. UBS Group raised Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Thursday, July 31st. Barrington Research reiterated an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. Finally, JMP Securities boosted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research note on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and an average target price of $35.75.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.